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Abstract 
Epilepsy is a neurological disorder characterized by the recurrence of 
spontaneous, unprovoked epileptic seizures. Mesial temporal lobe epilepsy 
(more briefly, MTLE) is a very common form of epilepsy which is featured by 
the occurrence of focal limbic seizures, and associated to a specific 
neuropathological alteration, the so-called Ammon’s horn sclerosis (AHS, 
from now on abbreviated as AHS), whose main features are a selective loss of 
the CA1 and CA3/4 section of the Ammon’s horn (CA, from Latin Cornu 
Ammonis, abbreviated as CA), a selective cell loss of inhibitory interneurons 
in the hilus of the dentate gyrus (DG), and the abnormal sprouting of granule 
cells mossy fibers (the so called mossy fiber sprouting, MFS). The onset of 
spontaneous recurrent seizures (SRS) is the hallmark of a good model of 
epilepsy. For temporal lobe epilepsy (TLE), the most used models consist in 
administering systemically chemoconvulsants inducing limbic status 
epilepticus (i.e. seizures lasting for more than 30’, SE) and evaluating the 
occurrence of SRS. However, in these models, the widespread involvement of 
different structures which complicates the interpretation of experimental 
findings obtained with this experimental approach, since any 
morphological/functional effect of these models might be due either to the 
direct action of the chemoconvulsant or to the SE. The morphological features 
of many structures of the limbic system are highly phylogenically conserved 
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through the evolution from rodents to primates and humans; it has been 
recently shown that it is possible to evoke limbic seizures and SE from a small 
structure, the deep extent of the anterior piriform cortex (from now on 
abbreviated as APC) by focally infusing picomolar concentration of 
chemoconvulsants; this structure roughly corresponds to the periamygdaloid 
cortex in humans. It is the brain region most densely innervated by the 
noradrenergic fibers originating from the nucleus locus coeruleus (LC), and 
we recently showed that microinfusing bicuculline  (a GABA A receptor 
antagonist) into the APC of rats with a lesion of LC (induced by a selective 
neurotoxin, DSP-4, i.p.), induces SE, similarly to the SE obtained by 
microinfusing into the APC of rats with an intact noradrenergic system, 
cyclothiazide+ bicuculline. LC plays a critical role in modulating several 
models of seizures, and it plays a critical role in plastic mechanisms and 
neuroprotection in the brain. Thus, we compared the group DSP-4+bicuculline 
and cyclothiazide+bicuculline, to evaluate whether the focal SE evoked from 
the APC is capable of inducing SRS and AHS, and whether LC plays a 
significant role in this phenomena. 
We found that: a) despite a similar duration and severity of SE in the two 
models of SE, in the group DSP-4+bicuculline there was a higher incidence of 
SRS; b) the cell loss in the hippocampal DG hilus and CA3 was higher in the 
group DSP-4+bic, while MFS was more intense in the group 
cyclothiazide+bicuculline; also the loss of parvalbumin-positive neurons was 
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more represented in the DSP-4+bicuculline group, while GFAP expression (an 
index of reactive gliosis), was similar in the two groups. 
In conclusion, our study confirms that focal induction of SE from the APC 
represents a good model of TLE, and that NE released from the fibers 
originating from the LC plays a significant role both in the hippocampal 
damage occurring after SE, and in the incidence of SRS. Differently from 
what observed in other models, our findings challenge a prominent role of 
MFS in the occurrence of SRS, since this phenomenon was less intense in the 
group with more frequent SRS (DSP-4+bicuculline) than in the one with an 
intact LC.
Chapter 1 General Introduction 
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Chapter 1 General Introduction 
1. Epilepsy 
The term Epilepsy describes a group of multifaceted diseases afflicting about 
0.5-2% (van den Broek and Beghi, 2004) of world population. Epilepsy is 
defined by the recurrence of spontaneous, unprovoked epileptic seizures. A 
seizure is the effect of hypersyncronous and excessive electrical discharge of a 
group of cortical neurons (Wyllie, 2001). There are several different types of 
epilepsies and seizures, depending on the etiology of the disease, and on the 
site of onset of the epileptic seizure. Seizures and epilepsies can be subdivided 
in to “generalized” or “focal” ones, depending on the localization of the 
epileptic discharge in a circumscribed region of the  cortex, or the involvement 
of the whole cortex. Generalized seizures can be further subdivided in 
primarily generalized (in which the seizure involves, from its onset, the whole 
cortex) or secondarily generalized ones, in which after a focal onset of the 
epileptic discharge there is a fast recruitment of the whole cortex.  
Depending on the aetiology, epileptic syndromes can be further subdivided in 
Idiopathic epilepsy or in symptomatic epilepsy, depending on the lack (in the 
former) or presence (in the latter) of any organic, structural brain defect. In 
many patients a diagnosis of “cryptogenic epilepsy” has been often made, 
when, even in the absence of a clear brain lesion at the neuroimaging, a 
symptomatic cause was still hypothesized (Commission on Classification and 
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Terminology of the International League  Against Epilepsy 1989). More 
recently (Engel, 2001), the latter form has been defined as “probably 
symptomatic”. 
 
a) Idiopathic epilepsy (Table 1)  
As said, Idiopathic epilepsies are characterized by the lack of any organic 
alteration of the brain, and are considered as likely to be linked to a genetic 
alteration. However, usually these disorders are not monogenic and 
transmitted through the generations as Mendelianan inheritance. Furthermore, 
as to now we have not identified yet any specific mutation present in all of the 
patients with a similar clinical phenotypes (e.g. childhood absences or 
myoclonic juvenile epilepsy), but just the mutations in single families, not 
confirmed in patients with similar disorders from other families (e.g., 
concerning Juvenile myoclonic epilepsy, see Delgado-Escueta  et al., 1990; 
Durner et al., 1991; and for childhood absence epilepsy, see Delgado-Escueta  
et al., 1990). Again, the single gene mutation responsible for the disease has 
been recently discovered only for some very rare idiopathic epilepsies, such as 
the sodium channel gene subunit genes (SCN1B, SCN1A, and SCN2A) and 
the GABA(A) receptor gamma2 subunit gene (GBRG2) mutations in 
“generalized epilepsy with febrile seizures plus” (Spampanato  et al., 2004; 
Liao et al., 2010; Mashimo et al., 2010);  voltage-gated K+channels of the 
K(V)7 (KCNQ) family mutations in the benign neonatal epilepsy (Maljevic et 
Chapter 1 General Introduction 
6 
al., 2008); and the mutations of the nicotinic acetylcholine receptor (nAChR) 
genes CHRNA4, CHRNB2, and CHRNA2  (Liu H et al., 2011) in “Autosomal 
dominant nocturnal frontal lobe epilepsy”, among others.  
 
b) Symptomatic epilepsy (Table 1) 
This group of syndromes comprises cases in which a well defined organic 
cause of epilepsy has been identified. This group represents by far the largest 
one, among epilepsies, especially after the introduction in the clinical setting, 
more than two decades ago, of magnetic resonance imaging (MRI).   Among 
the different causes of symptomatic epilepsy it is worth being mentioned the 
role of brain inflammation, tumors, trauma, stroke or infectious diseases 
(Singhi, 2011; Krakow et al., 2010; Yemadje et al., 2011; ). A different role is 
played by disorder affecting metabolism/electrolytes or the effect of poisoning 
by drugs or alcohol: in this case patients often experience a seizure only 
during such a systemic alteration, even though they are not “epileptic”  sensu 
strictu: these are defined mainly as “occasional”, “provoked” seizures, and are 
not considered as part of symptomatic epilepsy.  
Among focal symptomatic epilepsy there is one syndrome which is worth 
being described more in detail: the so called “MTLE associated to 
hippocampal sclerosis”. The reasons for its specificity are the frequent 
occurrence of it among epileptic patients, and the specific brain morphological 
alteration accompanying such syndrome. Furthermore, the most important 
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experimental models of focal epilepsy tried to model such a syndrome indeed, 
including the model we used in the present thesis. Thus, a specific chapter 
later will be devoted to such a syndrome and to its experimental models. 
 
2. Some molecular mechanisms underlying seizure onset 
One of the main functions of glial cells is regulating the ion environment in 
the brain. Glial dysfunction increases the extracellular K+ concentration, and 
this is considered as a potentially relevant factor for the onset of epileptic 
seizure (Frohlich, 2008; Traynelis and Dingledine, 1988; Feng and Durand, 
2006; Rutecki et al., 1985; Yaari et al., 1986). For the onset of an epileptic 
discharge, Ca
++
 influx into the neuron seems to represent the trigger step in 
most of the cases. There are two kinds of calcium channel which are the 
Ligand-gated ion channels (LGICs) and the voltage-dependent calcium 
channels (VDCC). In the physiological classical scenario, LGICs cause the 
depolarization current to reach the threshold of the activation of sodium 
channel causing the Na
+
 influx into the neuron. Afterwards, the VDCC is 
activated by the voltage change, and cause a further, massive and fast  Ca
++
 
influx. After that, K+ and C1- channels open, and Ka+ and Cl- outflow trigger 
the steps inducing neuronal repolarization. Such a neuronal cycle can be 
affected by several modulatory (or sometimes pathologic ones) mechanisms.  
When an excitatory neurotransmitter binds to its specific excitatory receptor, it 
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can activate the Ca + + channels to cause the Ca + + over-influx, resulting in a 
ion abnormal distribution inside and outside of the neuronal membrane, to 
cause an explosive release. 
By the same token, an excessive activation of neurons c an be caused by an 
abnormal reduction of the inhibitory tone on neurons. The permeability of the 
membrane to Cl- is increased when gamma-aminobutyric acid (GABA) binds 
to its receptors on neurons, thus maintaining the membrane potential in a 
stable level of resting potential and weakening its responses to afferent 
excitatory stimuli (see below). 
GABA concentration in the brain and spinal fluid has been found to be lower 
than in controls, both in epileptic patients and experimental epilepsy models 
(Wood et al., 1979; Petroff et al., 1998; Podell et al., 1997). A similar finding 
has been obtained in experimental models of seizures, such as the genetically 
epilepsy-prone rat (Lasley, 1991). As a further indirect proof for the role of 
GABA in experimental seizures, it has been shown that inhibition of GABAa 
receptor and of GABA/Cl- channel and the GABA synthetic enzyme-glutamic 
acid decarboxylase (GAD) dysfunction, (Ushijima et al., 1998; Schwartz et al., 
1989; Treiman, 2001; Walls et al., 2010) all could cause seizure. On the other 
hand, enhancing the activity or increasing GABA concentration can prevent 
seizure as witnessed by the potent antiepileptic effect of many antiepileptic 
drugs, which indeed act by potentiating the GABAergic inhibitory function 
(Jones-Davis and Macdonald 2003; Rogawski and Loscher 2004; White et al. , 
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2007). 
The GABA(A) receptor, the most represented subtype of GABA receptor, is a 
ligand-gated ion channel. It selectively conducts Cl-, and when it is open, Cl- 
enters the neurons causing hyperpolarization, i.e. an inhibitory effect. 
Interestingly, in some epileptic patients it has been found a mutation of the 
gene encoded the subunit of this receptor (Kumari et al., 2011, Kang et al., 
2010). Recently, a relationship between GABA(A)/central benzodiazepine 
receptor (GABA(A)/cBZR) density and the neuron loss and the mossy fiber 
sprounting (MFS) has been shown (Vivash et al., 2011).  
Glutamic acid and aspartic acid are the main excitatory neurotransmitters in 
the central nervous system (CNS). There are 2 kinds of glutamic receptors, the 
ionotropic glutamate receptors and metabotropic glutamate receptors(mGLuR). 
The N-methyl-D-aspartate receptor (NMDAr) is an ionotropic glutamate 
receptor and voltage-dependent channel, and allows Ca
++
 to enter into cells, 
thus depolarizing the membranes themselves. In patients with temporal lobe 
epilepsy it has been found that the concentration, synthesis and release of 
glutamate and aspartic acid increase, in parallel with an increase of NMDAr 
activity (Sherwin, 1999). In many experiments, it has been found that the 
inhibition of the NMDAr by competitive or non-competitive NMDA 
antagonists could stop or reduce seizures (Bausch et al., 2010; Obara. 1995; 
Ushijima, 1998; Cakil, 2011). Additionally, the NMDAr is related with the 
activation of the extracellular signal-regulated kinases (ERK) and the 
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Brain-derived neurotrophic factor (BNDF) signaling pathway. The cross-talk 
between BDNF and NMDAr in modulation of synaptic plasticity might have a 
relevant role in the chronic effects of epilepsy (Yamada and Nabeshima, 2004). 
On contrary, the agonist NMDA enhances the severity of seizures (Toscano et 
al., 2008). Recently, it has been found the subunit NR1of NMDAr is increased 
in patients with TLE (de Moura et al., 2010). 
The glutamic receptor a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
receptor (AMPAR), also defined as non-NMDA receptor, is another cation 
channel which mediates fast excitatory neurotransmission. Its permeability to 
Ca
++
 is governed by the subunit GLUR2 which prevents the Ca
++ 
to pass. By 
blocking this subunit it can prevent the excitotoxicity caused by several 
models of epileptic seizures (Kim et al., 2001). 
The kainate receptor (KAR) is the third type of ionotropic glutamate receptor; 
it is less known than the previous ones due to its low expression in the CNS. 
For several classes of neurons, KAR seems to be located presynaptically, and 
thus regulates glutamate and GABA release (Matute, 2010). It is believed to 
play a significant role in epilepsy in humans, even though we still lack direct 
evidences. However, incidentally it is worth being mentioned that the most 
popular model of limbic seizures and status epilepticus (from now on 
abbreviated as SE) in rodents, is the “Kainic acid (KA) model”, in which this 
agonist is administered either systemically of intracerebroventricularly (i.c.v.). 
Recently, some authors started studying also the role of mGluRs in the 
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mechanism underlying of epileptogenesis. For instance, it has been shown in 
vitro that the application of an antagonist of group I mGluR 
(S)-3,5-dihydroxyphenylglycine(DHPG), induces long-lasting epileptiform 
discharges (Bianchi et al., 2009) and that after this drug application, 
spontaneous inhibitory postsynaptic currents (IPSCs) are inhibited in the  
hippocampal CA3 region, due to the decrease of GABA release from the 
presynaptic nerve terminals (Inada H et al., 2010).  
 
3. Electrophysiological abnormalities of epilepsy 
More than three decades ago, it has been hypothesized that the onset of an 
epileptic discharge is associated, at the neuronal level, to the so-called 
“Paroxysmal depolarizing shift” (PDS) of the neurons within the epileptic foci, 
which is suggested to be the hallmark for epileptic activity in partial-onset 
seizures, followed by giant hyperpolarization (Ayala et al., 1983). It has been 
observed that the PDS can be initiated by release of glutamate from 
extrasynaptic sources (Tian et al., 2005). The characteristic of the PDS is the 
100-1800ms long depolarization caused by the activated AMPA channel to 
allow Na 
+
 influx to be depolarization, by which to activate the NMDA 
channel to caused the Na
+
 and Ca
++
 influx to cause action potential (Hwa et al., 
1991). This process is followed by the hyperpolarization which is caused by 
K+ outflux through the Ca
++
 dependent K+ channels or GABA-activated Cl- 
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influx, increased excitability, and decreased inhibition (Alger and Nicoll, 1980; 
Neckelmann et al., 2000; Traynelis and Dingledine,1988; McNamara, 1994; 
Timofeev et al., 2002). The epileptiform activity demonstrated at the EEG 
(Electroencephalography) level is the result of the synchronization of a large 
group of neurons undergoing PDS. (See figure 1) 
According the involved ion influx into cells in PDS, the PDS could be divided 
as Ca
++ 
dependent and Na
+ 
dependent (Pathak et al., 2009; Ure and Altrup 
2006). The synchronization due to the neurons respond to the PDS from other 
neurons by non-synaptic communication (Altrup, 2004 ; Altrup and Wiemann , 
2003) This PDS could be inhibited by the antagonist of NMDA and 
non-NMDA (Hwa, 1991; Segal, 1991; Gean and Chang, 1991), but is greater 
by antagonist of non-NMDA (Lee and Hablitz, 1991); the GABAAr and 
GABABr play different role in the PDS duration and frequency and the 
afterdischarge (Siniscalchi et al., 1998; Bijak and Misgeld, 1996). 
As said, another feature of a seizure is the hypersynchronization of a group of 
neurons. While for primarily generalized seizures it has been postulated that 
subcortical “broadcasting structures” (such as for instance some thalamic  
nuclei) can simultaneously involve large part of the cortex through effective 
non-specific projection pathways, groups of cortical neurons can be 
hypersynchronised with each other by several ways, which are often 
non-synaptic in nature. For instance, by electrophysiological techniques on 
brain slices, by ion-selective electrodes (Heinemann et al., 1977; Pumain et al., 
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1985) it has been shown during repeated discharges, such as those occurring 
in epileptic tissue, extracellular calcium levels decrease in such a way to even 
abolish the chemical synaptic transmission. At the level of the hippocampus, it 
has been shown that epileptiform activity is accompanied by negative shifts 
(field bursts) in the extracellular field potential slowly propagating across the 
CA1 pyramidal cell layer, and by a transient increase in extracellular 
potassium and diffusion of an extracellular potassium wave, which could 
facilitate the non-synaptic burst propagation (Yaari et al. 1986). Again, a 
synchronization of a number of neighbo ur neurons with each other can be due 
to trans-synaptic positive feedback mechanism: this has been speculated to be 
the case for hippocampal sclerosis at the le vel of mossy fibers (see below). 
Other mechanisms proposed for hypersynchronisation is abnormal/excessive 
electrical coupling between neurons, or diffuse massive release of 
neurotransmitter in a relatively wide area. When both the abovementioned 
hyperexcitability (e.g. PDS, see above) and hypersyncronisation of a certain 
number of neurons reach a “threshold” it can overwhelm self-limiting 
mechanisms, giving rise to a seizure occurrence. 
In this scenario, it can be understood why a GABA receptor blockade can 
trigger seizure occurrence (blocking the inhibitory effect of a tonic GABA 
receptor activation), or why a hyperactivation of glutamatergic receptors can, 
vice versa, trigger a seizure by the opposite mechanism. 
By the opposite token, this can explain also why GABAergic drugs are 
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routinely used to shorten, stop or even prevent seizures, and (but mainly in the 
experimental setting, due to the relevant adverse effects of such class of drugs) 
agents blocking AMPA or NMDA glyutamatergic receptors can have a similar 
effect.  
 
4.  Anatomical basis for seizure spreading and synchronization of 
different cortical structures 
Apart from the above mentioned cellular/molecular mechanisms, several 
authors have studied in details, in the last decades, the pathways involved in 
the onset and spreading of epileptic seizures. Among them, Dr Karen Gale, 
from the Department of Neuroscience of the Georgetown University proposed 
an elegant model explaining several experimental findings in different animal 
models of epilepsy (Gale, 1992). 
In particular, she defined a scenario in which, the main characters of a certain 
type of seizure, from an anatomical point of view are:  
 
1) TRIGGER AREA: This is the specific site in the brain from which seizure 
onset can be triggered by focal electrical or chemical stimulation (Piredda and 
Gale, 1985). Gale pointed out, that this area is not necessarily the first area 
exhibiting ictal activity during the development of seizure, and to show the 
same ictal activity. In other words, this implies that even non-cortical 
structures, and brain nuclei formed by neurons with receptorial/neurochemical 
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features even very different from the “epileptic cortex” can be the starting 
point of a seizure. Some nuclei of the amygdala, and the deep pre-piriform 
cortex (the site of seizure induction we chose for this thesis, see below) are 
great examples of this concept, since they possess an extremely low threshold 
to triggering limbic and generalized seizures after microinfusions of 
nanomolar or even picomolar amounts of chemoconvulsants, and to very low 
electrical stimulation (see below). 
 
2) TARGET AREA: this is an area which is particularly prone to the 
development of ictal activity, either due to its anatomical connection with the 
trigger area, or by its intrinsic circuits. It is the first cortical site recruited by 
the seizure, and, even more important, the one  determining the early 
phenotypic features of a seizure.  
 
3) PATHWAY OF SEIZURE PROPAGATION: This is the pathway 
connecting the trigger and the target areas with each other. It can create in 
some circumstances positive feedback circuits, and even allow the seizure to 
spread to other brain regions (Gale, 1988). They also include the commissural 
pathways involved in the bilateral spreading of the seizures. 
 
4) GATING AREAS: This is perhaps the most innovative concept of the 
Gale’s model. The Gating Areas are areas whose activity modulates the 
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excitability of the trigger areas or target areas, but which do not trigger nor 
cause any seizure per se when stimulated (Gale, 1985). Experimental models 
of seizures have disclosed the existence of several gating areas, among which 
there are, for instance, the substantia nigra pars reticulat a, the superior 
colliculus or some thalamic nuclei. The importance of this concept is the fact 
that, at least theoretically, pharmacological/surgical manipulation of these 
structures could strongly affect seizures. 
 
5.  General aspects on experimental models of seizures and epilepsy 
In table 2, we report the main features of a “good” animal model of 
neurological disease. Despite the first attempts to study epilepsy in 
experimental models date back to several decades ago, thus far there aren’t 
many models of human epileptic syndromes. In fact, the phylogenetic distance 
between humans and rodents is often the cause of the difficulty to reproduce 
in the animal, despite having the same pathological lesion or genetic mutation, 
a pattern of seizure equivalent in the human being. Moreover, an implicit 
assumption of this kind of models is the possibility to reproduce in the animal 
a real epileptic condition, considered as low epileptogenic threshold and the 
occurrence of SRS.  
On the contrary, there are many models of epileptic seizures. In this case the 
main objective of the experimenters is to induce acute critical episodes 
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resembling human seizure, on the behavioral and/or EEG and/or 
pathophysiologic perspective (see 1981 ILAE classification of seizure). In this 
setting, however, unlike the previous group of models, seizures are not 
spontaneous, but acutely induced after various experimental manipulations 
done by the researchers. It is easy to imagine how the two types of approaches 
are used for two different purposes: the first, i.e. the reproduction of an 
epileptic condition, which is the most recent, has the aim of understanding the 
pathogenesis of epilepsy. In the second case, i.e. the induction of acute 
seizures, experiments are performed mainly with the aim of developing fast 
and repeatable tools to test the effectiveness of anti-epileptic drugs (AEDs) on 
the different kind of human seizure.  
It is obvious, however, that the latter approach is of limited usefulness in 
studying epilepsy proper. 
In the following paragraph, we will focus on models of limbic seizures and 
epilepsy, since one of these models form the basis of the present thesis, while 
a complete description of the remaining experimental approaches for different 
types of epilepsy is beyond our aims. However, a concise list of the available 
experimental models of epilepsy is presented in (Table 3) 
 
6.  Mesial temporal lobe epilepsy: anatomical specificity, clinical features 
and experimental models 
The experimental model used for this thesis is specific for the so-called 
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“limbic seizures” and “limbic epilepsy”. It has been developed for addressing 
specific physiopathological issues related to a very common form of epilepsy, 
the so-called MTLE. In this paragraph, we will address at first the anatomical 
structures forming part of the limbic system, and then we will briefly discuss 
the experimental models of MTLE. 
 
a) The limbic system  
The term limbic system dates back to the 19
th
 century, to indicate cortical 
structures which, without interruption, sourround (thus form a “ring”, i.e. 
limbus in latin) the brainstem and the corpus callosum. This term has been 
used, along the last decades, to indicate different brain structures slightly 
varying from author to author. Nowadays, there is a general agreement by 
many authors in the field, in defining the limbic system as that part of the 
brain which is directly involved in emotional modulation, memory storing, 
and in the regulation of visceral functions. Thus, being such a definition 
exquisitely functional, from an anatomical  point of view it includes both 
telencephalic and diencephalic structures. The concept of limbic system as a 
“ring” surrounding the brain stem and hippocampus has been more recently 
substituted by the term “limbic lobe”, while actually the term  limbic system 
includes: a) the limbic lobe, b) the hippocampus, c) the hypothalamic 
mammillary bodies, d) the mediodorsal and anterior thalamic nuclei, e) the 
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amygdala. A slightly wider definition includes also: a) the claustrum; b) the 
anterior perforated substance, c) the piriform nuleus; d) the olfactory tubercle; 
e) the septal nuclei.  
The limbic lobe is formed by the orbital part of the frontal cortex, the 
parahippocampal cortex and the pole of the temporal lobe, which includes the 
so-called uncus of the hippocampus formed by the cortex laying right above 
the amygdale, which can be further defined, according to some authors, as 
“piriform lobe”, due to its shape in rodents, and which can be further divided 
in: a) prepiriform cortex; b) periamygdaloid cortex (also called perirhinal 
cortex), and c) enthorinal cortex. The limbic lobe is considered as an 
associative limbic area, involved in memory (especially the memory for old 
events), and in generating the emotional drive for different behaviors, 
involving both ancient instinct and evaluation of risk/benefits of events (due to 
its connections with several neocortical associative areas).  
Conversely, the part of limbic system formed by the amygdala and 
hippocampus is involved in recent memory and fast, instinctive visceral and 
emotional behaviors.  
The hippocampal formation is placed within the mediodorsal part of the 
temporal lobe. It is involved, among other functions, in working memory 
formation.  It is formed by: a) the CA, b) the dentate gyrus (from now on 
abbreviated as DG, and subiculum, which are cortical formations forming a 
continuum with each other, c) the fimbria, which is formed by white matter 
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and is placed above the DG. The CA is formed by a pyramidal cell layer 
which is the continuation of the subiculum and ends at the level of the hilus of 
the DG: the latter part of this pyramidal layer is called the CA4, or endfolium, 
while the part closer to the subiculum is called CA1 region. The DG is a 
c-shaped neuronal layer formed by the so-called granule cells, which are 
glutamatergic neurons, which give rise to fibers called “mossy fibers”, which 
end at the level of the hilus of the DG itself, impinging on interneurons, and at 
the level of the CA4 and CA3 pyramidal cells dendrites. The interconnections 
existing between the different parts of the limbic system and the hippocampus 
are complex in nature, as well as the wide numer of intrahippocampal 
connections (often involving different kinds of interneurons), and we will not 
describe them in detail. 
It is worth being mentioned in this paragraph that:  
a) the main source of afferent signals to the hippocampus is through the 
excitatory projection of neurons from the enthorhinal cortex to the granule 
cells of the DG, via the so called “perforant path”; 
b) the DG and the CA are strongly connected by the glutamatergic mossy 
fibers (see above); 
c) the efferent fibers originating from the CA pyramidal cells converge in the 
alveus, but CA3/CA4 neurons send also axon collaterals, the so-called 
“Schaffer collaterals”,  contacting the dendritic trees of pyramidal cells of 
CA1at the level of stratum radiatum and stratum oriens.  
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Efferent fibers from the CA get, through the Fimbria, to the Fornix and, later 
on, to the mammillary bodies; the latter send connections to the “limbic 
thalamic nuclei”, i.e. the mediodorsal and anterior thalamic nucleus.  
Other efferent fibers from the hippocampus originate from the CA1 cells, and 
reach the enthorhinal cortex; the latter one sends in turn projections to other 
associative isocortices. Interestingly, while most authors in the last century 
considered the Fimbrio-Fornix efferent pathway (being part of the so-called 
Papez memory circuit), as the most important hippocampal efferent pathway, 
more recently it has been shown that the projection back to the enthorhinal 
cortex is the most important one, and plays a significant role in memory 
processes.  
Finally, it is important to note that the amygdala is in strict interact ion with the 
periamygdaloid and pre-piriform cortex, which in turn are widely 
interconnected with the enthorhinal cortex (the main source of afferents to the 
hippocampus-see above). Incidentally, the prepiriform cortex is the primary 
olfactory cortex, and in rodents it plays a critical role in integrating olfaction 
(the main source of sensitive impulses in these species) with the visceral and 
instinctive functions of the limbic system: in this experimental study we 
microinfused chemoconvulsants in a portion of this brain region in rat (see the 
remaining parts of the thesis). 
Finally, since the limbic structures are all phylogenically very old, they show a 
significant persistence of the general cytoarchitecture through evolution: thus, 
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the same areas, even though, of course, placed differently in the context of the 
brain, can be identified, and share similar connectivity with each other, in 
rodents and in primates and humans (See figure 2) exemplifies as the 
prepiriform cortex (which is the site chosen to be microinfused in our model 
of limbic seizures), and other limbic structures can be identified through 
phylogenesis.  
 
b) Human mesial tempral lobe epilepsy syndrome: 
In humans epilepsy frequently affects limbic structures, determining the 
so-called “MTLE”. This form of epilepsy accounts, by itself, for almost 30% 
of all patients affected by epilepsy. As it can be hypothesized intuitively, the 
limbic system can be affected by several different kinds of lesions. 
Nevertheless, since more than 70% of all patients affected by MTLE bear the 
so-called “hippocampal sclerosis” (see below for a detailed description), and 
several clinical aspects are specific for most of the patients affected, the latter 
has been definitely defined as a specific epileptic syndrome  (Engel, 2001; 
Panayiotopoulos, 2002). From now on we will simply refer to MTLE with 
hippocampal sclerosis just as MTLE. 
Patients affected by this syndrome experience mainly focal seizures, starting 
at the age of 10-15 years. These seizures are featured mainly by an impairment 
of consciousness and by these reason they have been defined for long time as 
“psychomotor seizures”, or “complex partial seizures”, as opposite to “simple 
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partial seizures” in which there are either only motor or only sensitive ictal 
manifestations without any consciousness involvement. Typically, the patients 
have a sudden arrest of their attention/speech. During this time they can 
continue speaking in a stereotyped manner, mainly by repeating passe-partout 
words. After the seizure, which usually lasts not longer than 1-2 min, they 
start again with their normal behavior: sometimes they continue the 
conversation they were having before the seizure. These seizures are very 
often associated with motor manifestations usually in the forms of 
oroalimentary automatisms (in 70% of cases), or stereotyped movements of 
the arms, and sometimes associated also with an increase in muscular tone on 
one side’s limbs. In some cases these focal seizures can generalize giving rise 
to generalized tonic-clonic seizures, but the latter are rare when the patients 
are under appropriate antiepileptic drugs. Finally, a very typical feature of the 
seizures occurring in MTLE is that  these seizures are preceded by symptoms 
which, up to very recently were called “aura”, featured by either an epigastric 
discomfort/nausea, or cacosmia, or a déjà-vu/déjà-veçu sensation. This “aura” 
is actually a focal seizure per se, which manifests with one of these 
phenotypes depending on the precise site of origin. 
Most of patients affected by MTLE have experienced during infancy febrile 
seizures, and expecially the most “atypical ones”, which are featured by long 
duration and post-ictal paralisis. Etiologically it has been believed for long 
time that these seizures per se, either caused by a lesion nearby, or occurring 
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without specific reasons, caused the occurrence of hippocampal sclerosis, and, 
subsequently, MTLE. 
As said the hallmark of MTLE is the “hippocampal sclerosis”. This is called 
also AHS. It was first described in 1966 by Margerison and Corsellis in a 
cohort of epileptic patients submitted to surgery for TLE (Margerison and 
Corsellis 1966). The main morphological features of AHS are: a) atrophy of 
one hippocampus at gross inspection; b) selective piramidal neuron loss at the 
level of CA1, CA3 and CA4 sub-field of the Cornu Ammonis; c) loss of 
interneurons within the hilus of the DG: these neurons have been claimed to 
be mainly GABAergic interneurons; d) Mossy fiber sprouting: by selective 
coloration (by an histochemical method, TIMM staining, which selectively 
stains Zn-containing fibers) mossy originating from the glutamatergic granule 
cells of the DG, it has been shown that in AHS there is a dense re-innervation 
of the dendrites of granule neurons by their axons themselves. This, 
functionally, configures the anatomical basis for an autoexcitatory circuit; e) 
ractive gliosis of the hippocampus, which is usually revealed by testing the 
expression of glial fibrillary acid protein (GFAP) expression (a hallmark of 
astrocytes); f) more recently, also granule cell dispersion within the DG has 
been observed in most of AHS cases. (Blumcke et al., 2002)(See figure 3) 
Often, hippocampal sclerosis in unilateral; however in many cases as well it 
has been observed, even though less evident on one side versus another, the 
occurrence of AHS bilaterally: this has been considered by several authors as 
Chapter 1 General Introduction 
25 
the effects of the spreading of seizures on the contralateral side of a first 
hippocampal lesion, and the cause of the so-called “mirror focus”, i.e. the 
onset of new seizures from the contralateral hippocampus (Morrell and 
deToledo-Morrell, 1999). 
Hippocampal sclerosis can be, nowadays, clearly defined also on MRI images, 
and this facilitates significantly the diagnosis of MTLE in mild forms. 
Furthermore, this epileptic syndrome is particularly resistant to antiepileptic 
drugs, since up to 50% of patients, in the different casistics, need more than 
one drug and is often not seizure-free. The etiological link between the 
presence of AHS and seizure occurrence has been demonstrated by the good 
remission in many pharmacoresistant MTLE patients undergoing surgical 
removal of the affected temporal lobe. 
 
c) Animal models of limbic seizures and epilepsy 
c1) Focal induction of acute limbic seizures 
Limbic seizures can be induced acutely by stimulating electrically different 
brain sites, but also by applying electrical stimuli through the corneas . In this 
setting, just by increasing the intensity of electrical stimulation it is possible to 
recruit gradually various cerebral structures and, accordingly, induce different 
seizure types. Thus, for low current  facial clonus, forelimb clonus till to lift 
the hind limbs then fall down can be observed, and this can be considered a 
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quite “limbic onset” stereotyped seizure pattern in rats, since a similar 
behavior is observed after low stimulation of the amygdale or hippocampus . 
Higher currents, however, even induce “running-bouncing”, and even higher 
currents cause hypertonia with flexion or extension of hind limbs: the latter 
behavioral phenotypes show a progressive involvement of the whole cortex as 
well as of brainstem structures. 
It is of interest to note that when an electrical stimulation is delivered through 
the electrodes earphone the first manifestation are those “running-bouncing” 
which is a sign of early recruitment of the structure of hindbrain (brainstem). 
 
c2) Systemic injection of chemocovulsants 
Systemic administration of KA (a glutamatergic agonist) or pilocarpine (a 
muscarinic cholinergic agonist) can induce limbic seizure, in a fair percentage 
of the animals treated. Actually, in those animals these substances induce 
often a true “SE”, i.e. seizures lasting longer than 30’ without interruption.  
In particular, the systemic (or i.c.v) injection of KA causes tonic-clonic 
seizure, through the same sequence of behavioral patterns described above, 
thus testifying an initial involvement of limbic structures (which bear the 
lowest threshold to KA induced seizures). In line with this, Lothman and 
Collins (1981), classified the seizure evoked by KA in rats in four distinct 
stages, which rose to 6 in the latest classification of Zhang et al. (1997).  
Chapter 1 General Introduction 
27 
In the latter classification Stage 6 defines the occurrence of SE, independently 
from the behavior. Typically, stage 1, 2 and 3 describe staring, clonus of on 
forelimb and of both ones, respectively. Afterwards rearing and falling can be 
observed. All these motor manifestation continue up to the occurrence of SE, 
which occurs between 1.5 and 3 hours after injection and the most severe 
situations is accompanied by jumps, rotational movements, staggering, intense 
agitation and wild ride, which continues for hours. Often, animals experience 
SE till to die. 
Only <1% of the injected KA can penetrate into the brain because of the 
existence of BBB (Blood Brain Barrier). After KA administration the neurons 
of olfactory cortex, amygdala complex, the APC get lesioned within 24-36h. 
The major selective lesions to hippocampus are the CA3 area pyramidal cells, 
interneurons of the hilus of the DG, and to the CA1 region, but much less to 
area CA2 and the granule cells. the fact that hippocampus is always involved, 
with the main damage at the level of neurons of areas CA1, CA3 and some 
interneurons of the hilus and of the DG, has provided the basis for considering 
this approach, by some authors, as a model of MTLE. 
Another model of acute “limbic” seizures is the pilocarpine model. High 
doses of pilocarpine (up to 400 mg/kg, Turski et al 1984) induce, even in this 
case, limbic seizures at first, followed soon by secondarily generalized 
seizures together with the appearance of SE. The lethality in the next 24 hours 
is very variable and strain-dependent. Even in the case of pilocarpine, brain 
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damage widely involves the forebrain (Turski et al., 1984); hippocampus, 
thalamus, amygdala, olfactory cortex, neocortex and substantia nigra are 
interested with a pattern similar to that induced by of glutamate excitotoxic 
drugs (Olney et al., 1986). EEG recording performed during the seizure show 
actually the sequential development of the abnormal activity in the forebrain, 
with the earliest changes at the level of the hippocampus, amygdala, and 
subsequently the involvement of the whole neocortex (Turski et al., 1983a; 
Turski et al., 1983b; Turski et al., 1984). 
Even in this model of limbic severe seizures one of the earliest lesions regards 
the interneurons of the hilus of the DG and the pyramidal neurons of the areas 
CA1 and CA3 of the hippocampus. 
In both KA- and pilocarpine-induced SE, chronic plastic changes, such as 
MFS can be observed (Sloviter, 1994).  
As said, both models cannot be claimed as models of temporal lobe epilepsy, 
since the systemic injections of chemocovulsants induced cellular losses in 
sites distant from the limbic areas. They cannot be even considered as good 
models of “the deleterious effects of limbic SE”, since the degenerating 
phenomena are due not only to the limbic SE, but also to the direct effect of 
the chemoconvulsant on several brain sites (i.e. those bearing the specific 
receptors). Consequently, the pattern of neurodegeneration, resulting by these 
treatments, doesn’t correspond necessarily to the result of the pure epileptic 
activity, but could be a result of the direct stimulation of large brain areas.  
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c3) A classical model of limbic seizures in the rat: the “kindling” 
Kindling of limbic structures has been considered by several authors a model 
of limbic epileptogenesis resembling what occurring in TLE. It consists in 
repeated sub-threshold electrical stimuli of the same brain site (either 
amygdale, the most frequently tested, or hippocampus or perforant pathway), 
resulting in gradual increase in the intensity of seizure activity, culminating in 
generalized seizures, (i.e. a “Kindling” of the brain, in terms of excitability). 
Such effects, furthermore, are persistent (or in some cases permanent), since a 
low electrical stimulus of the same brain site weeks/moths after the kindling 
induction, still induce severe seizures. Furthermore, sometimes rats even 
experience spontaneous seizures and chronically abnormal EEG, even though 
no specific lesions can be observed at the level of the stimulation site. 
Furthermore, epileptogenicity often is transferred, after several stimulations, 
also to the contralateral same site, to form the so-called “mirror” focus, a 
phenomenon often observed also in humans affected by TLE this is similar to 
the clinical characteristics of human epilepsy (Van de Bovenkamp -Janssen et 
al., 2004). For these reasons limbic “kindling” is considered by several 
authors as an interesting animal model of epilepsy. However, one of the main 
weaknesses for considering it as a good tool to study TLE, is the fact that, 
independently of the site of kindling induction in the limbic system, in no case 
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it has been observed a pattern of hippocampal degeneration similar to AHS. 
Thre “kindling” method has been developed by Goddard starting in the 70’s 
(Goddard, 1982). This author initially used trains of 60 Hz frequence, 1ms of 
wavelength, 1s of string length, to stimulate the amygdala once a day. 
Subsequently this model had been improved by Lothman with different 
current and the different position (Lothman et al., 1985).  
The limbic structures more often stimulated in order to induce kindling are the 
amygdala, the piriform cortex, the hippocampus, the enthorhinal cortex and 
some other limbic regions. In any case, among them the most sensitive to 
kindling are the amygdala and the hippocampus. 
Some authors have also induced “chemical” kindling by administering rats 
with low, repeated, doses of chemoconvulsants, such as PTZ, penicillin, 
picrotoxin, kanic acid and pilocarphine. In some cases these drugs induce 
kindling in a few hours (the so-called “fast kindling”), and often induce 
spontaneous chronic seizures (Giorgi et al., 2003). The chemical kindling is 
different with intracerebral kindling, as its no harm to the brain tissue, but the 
drugs has its own toxicity at high dose, and to give lesion to the brain. 
Interestingly, in the case of kindling, differently from what observed when 
using the same chemoconvulsants at high doses, no specific brain damage are 
usually observed. 
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c4) Focal microinjections in the APC of rat   
In recent years a new experimental model has been developed in order to 
minimize the possibility of the nonspecific effect which accompany the 
traditional models of TLE induction in vivo. This model is based on the 
microinfusion of the chemoconvulsants into specific “trigger” areas 
(according to Dr Gale’s definition, see above). As already said, once triggered 
these neurons, the seizure propagates through the normal interneuronal 
connections to target areas. It is worth being stressed again the concept that, i n 
the case of neuropathological, or even just “functional” and “molecular” , 
changes in sites distant from the trigger area, these effects can be claimed to 
be the sole effect of seizure propagation per se rather than of the direct effect 
of the chemoconvulsants.  
In a study performed to test the threshold to trigger seizures of different 
cortical sites in the limbic system of the rat, Dr gale discovered some decades 
ago, that the anterior extent of the deep prepiriform cortex, also called more 
briefly as APC is by far the most sensitive trigger site: the microinfusion of 
picomolar dose of bicuculline (a GABA-A antagonist) in this site is sufficient 
to trigger seizures (Piredda and Gale, 1985; Gale, 1992; 1995). Furthermore, it 
has been recently shown that even SE can be elicited from the APC, by the 
combined infusion of substance which acts on the different receptor systems. 
It has been observed with bicuculline+carbachol (a cholinergic agonist), KA+ 
carbachol, bucuculline + cyclothiazide (an inhibitor of the desensitization of 
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the receptor of the AMPA subtype of glutamate receptor), or AMPA 
(2-amino-3-(5-methyl-3-oxo-1,2- oxazol-4-yl)propanoic acid) propanoic acid, 
an antagonist for the AMPA receptor) + carbachol in APC (Fornai et al., 2005). 
Surprisingly, the SE obtained by these approaches persists beyond the half-life 
of the microinfused substances, thus being defined as “self sustaining”. Such a 
phenomena is somehow generated by the interaction between the cholinergic, 
glutamatergic and GABAergic neurons localized in the micro-infusion areas, 
since to prevent SE it is sufficient to remove one of these components.  
However, we do not know in detail, yet, the specific mechanisms by which 
such a phenomenon appears, nor it has been investigated in detail the long 
lasting effect of SE evoked from the APC. 
 
7.  Neuromodulators of seizures and epilepsy: the role of Locus 
Coeruleus 
a) The nucleus Locus Coeruleus (Figure 4) 
The LC is the main noradrenergic nucleus in the brain. It is located in the pons 
at the level of the upper part of the floor of the fourth ventricle. A specificity 
of its neurons is their extremely branched projections which allow each one of 
them to innervate many subcortical structures and almost the whole cortex. 
LC receives afferents from the hypothalamus, cerebellum and raphe nuclei, 
and the amygdala. The two main ascending fiber systems originating from the 
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LC are the dorsal bundle and the much smaller rostral limb of the dorsal 
periventricular pathway are innervations. Norepinphrine (Herein abbreviated 
as NE) released by the LC neurons is considered to play mainly 
neuromodulatory effects. In fact, the efferent fibers originating from the LC 
possess a lot of  varicosities, and NE is released from those extra-synaptic 
structures rather than at the level of classical synaptic formations; thus, NE 
released along LC fiber terminals affect the surrounding structures in a 
paracrine fashion. As the NE terminals are in close contact with astrocytes, 
microglia and microvessels, LC affect significantly the function of the BBB 
and glial function (Harik and McGunigal, 1984). By the releasing of NE into 
many brain structures, LC can regulate a variety of important CNS functions: 
it modulates electroencephalographic (EEG) activity (Foote et al., 1983); 
regulates the sleep-waking cycle (Jouvet, 1969; Aston-Jones and Bloom, 1981) 
and significantly affect arousal and vigilance (Aston-Jones et al., 1991); 
furthermore, it seems to play a specific role in alerting and orienting to 
novelty (Aston-Jones et al., 1994).  
From a molecular point of view, most of the above mentioned effects appear 
to be related more or less directly, to transcription in the target neurons of the 
so-called immediate early genes (IEG) such as c-fos and nerve growth 
factor-induced A (NGFI A), nur 77, tis-7, zif-268 and tis-21 in LC target 
neurons (Gubits et al., 1989; Bing et al., 1991). This effect has been 
demonstrated in basal conditions (Bing et al., 1991), both during stressful 
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stimuli (Stone et al., 1993) and during seizures (Simler et al., 1999). In line 
with this, LC-dependent circadian rhythm of early gene expression can 
regulate the state of phosphorylation of cyclic adenosine monophosphate 
response element-binding (CREB) proteins (Cirelli et al., 1996). The IEGs are 
suppressed during the REM (Rapid eye movement) sleeping and express 
strongly during the wakefulness (Cirelli et al., 1996). Furthermore, it has been 
shown that a previous lesion of LC terminals, by DSP-4, significantly 
attenuated the expression of Fos protein associated with SE (see below-), and 
this might have relevant effects in the plastic mechanisms related with 
epileptogenesis attenuated the expression of Fos protein associated with SE 
(Giorgi et al., 2008). 
Finally, it is worth being mentioned in this setting that LC neurons 
spontaneously degenerate in physiological ageing, as it has been estimated 
that while in young adults LC contains approximately 60000 neurons, in 
healthy aged people this number decreases up to approx. 40000 neurons 
(Baker et al., 1989; Iversen et al., 1983) 
 
b) The role of NE in epilepsy and experimental seizures 
It is worth to be mentioned that while in the last decades there have been a 
huge amount of experimental data on the role of NE in a variety of epilepsy 
models, there are, on the contrary, only a few indirect evidences for its role in 
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human epilepsy, mainly because of the lack, nowadays, of neuroimaging 
techniques allowing to investigate in vivo the structure and function of LC in 
humans. Among the indirect clues, it is worth being mentioned that there are 
robust epidemiological evidences for a much higher incidence of endogenous 
depression among epileptic patients (independently from any therapeutic drug) 
than in the control population, and it has been demonstrated by several authors 
a significant role of NE in depression pathogenesis (Kanner, 2011; El Mansari  
et al., 2010). Thus some authors even suggested that, in selected cases, NE 
deficit might contribute to the onset of both epilepsy and depression in the 
same patient (Jobe et al., 1999).  
As said there are several experimental evidences for an anticonvulsant effect 
of NE. A proconvulsant effect of damage  to the NE system has been proven, 
by profiting of monoamine-depleting agent reserpine (Chen et al., 1954) , or 
by selectively lesioning the LC in models of audiogenic seizures (Jerlicz et al., 
1978), metrazol-induced seizures and seizures induced by electroshock 
(Mason and Corcoran, 1979). A reduced threshold to different epileptogenic 
insults has been observed by using the selective LC neurotoxin DSP-4, 
(Mishra et al., 1994). Conversely, LC stimulation suppresses seizures induced 
by PTZ (Pentilentetrazolo), amygdala kindling and focal hippocampal 
penicillin application (Libet et al., 1977; Weiss et al., 1990; Ferraro et al., 
1994). 
Again, an indirect proof of a role of NE in eileptogenicity is provided by the 
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observation that both in genetically epilepsy prone rats (GEPRs) and tottering 
mice, which are susceptible to seizures, there is a congenital alteration of LC. 
In particular, GEPRs have been discovered due to their proneless to develop 
seizures after audiogenic stimuli; they also show a low threshold to several 
epileptic stimuli, such as electroshock and PTZ (Browning et al., 1990), 
fluorothyl (Franck et al., 1989), limbic kindling (Savage et al., 1986). In this 
rat strain several NE parameters alterations have been observed, such as 
reduction of NE levels (Jobe et al.,1973; 1984; Dailey and Jobe, 1986; Dailey 
et al., 1991), dopamine-beta-hydroxylase (DBH) actvity (Browning et al.,1989) 
and immunoistochemistry (Lauterborn and Ribak, 1989) reduction, as well as 
NE uptake sites reduction (Browning et al.,1989). In tottering mice, it has 
been shown, conversely, an excessive autoinnervation of LC cell bodies, 
which is believed to induce auto-inhibition of the nucleus itself (Levitt et al., 
1987). 
 Other strains of mice bearing specific, known mutations affecting 
noradrenergic parameters have an abnormal threshold to epileptic seizures. 
For instance, the D79N mice bearing a mutation of alpha-2 adrenergic 
receptor which induces a significant loss of receptorial function (Ceresa and 
Limbird, 1994): these mice are much more susceptible to amygdale kindling 
than wild type (WT) mice (Janumpalli et al., 1998). It has been observed a 
significant incidence of spontaneous seizures when mice overexpressing alpha 
1B-adrenergic receptors; furthermore, the degree of activity of the 
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overexpressed alpha1B-adrenergic receptors (alpha1B ARs) is related with the 
severity of spontaneous seizures; in these mice, seizures can be partially 
reversed by the alpha1 ARs antagonist, confirming that the alpha1 ARs 
signaling sustains seizure activity (Kunieda et al., 2002).  
 
c) The role of Locus Coeruleus on seizures evoked from limbic sites and 
APC 
Stepping back to the role of NE in acquired experimental seizures, there are a 
lot of evidences of the involvement of LC in limbic seizures and epilepsy. 
Concerning amygdale kindling, it  has been clearly shown that there is a 
significant increase in the kindling rate in the amygdala after a selective 
lesions of NE fibers belonging to the dorsal forebrain bundle, which indeed 
produces a parcellar selective loss of the NE innervation to limbic and 
neocortical areas (Corcoran and Mason, 1980). An opposite effect is provided 
by increasing NE activity, either by NE uptake blockade (McIntyre et al., 1982) 
or by direct stimulation of LC (Jimenez-Rivera et al., 1987): both approaches 
delay amygdala kindling. The antiepileptogenic effect of NE on kindling is 
confirmed by in vitro studies on slices collected from the 
piriform/periamygdaloid cortices (McIntyre and Wong, 1986). 
The APC is a part of the olfactory cortex, which possesses the highest NE 
content in the brain (Giorgi et al., 2003; 2006) and is particularly prone to 
trigger seizure by microinfusion of chemocovulsants (see above). While 
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seizures evoked by bicuculline infusion into the APC are isolated, sporadic 
seizures, each one lasting not longer than 30”-1 min’, the microinfusion of 
bicuculline into APC of rats previously treated with DSP-4 converts the 
seizure into a long-lasting, self sustaining status epileptic which shows NE 
deficit provoked a persistent modification in the responsiveness of neural 
epileptic circuitries (Giorgi et al., 2003). Furthermore, the NMDA antagonist 
and non-NMDA antagonists prevent the SE in the rats with intact LC but the 
NMDA antagonist is ineffective in the rats with the LC lesioned. AHS is 
observed in many patients with MTLE, this neuronal damage could be caused 
with less seizure duration caused by bicuculline infusion into the APC in NE 
lesion rats, suggesting a specific neuroprotective effect of endogenous NE 
(Giorgi et al., 2003).  
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Chapter 2 Experimental Section 
1.  Introduction to the experimental section 
As said repeatedly in the General Introduction, MTLE is by far the most 
diffuse form of focal epilepsy. The main feature of epilepsy is the presence of 
“SRS”. There are several models of limbic seizures, as extensively described 
above. However, only recently authors involved in the epilepsy field have 
started to describe models of SRS, rather than of just acute limbic seizures. It 
has been shown repeatedly that after a strong insult, such as the induction of 
limbic SE by systemic administration of chemoconvulsants (e.g.KA or 
pilocarpine), both in rats and in mice there is the development of SRS 
(Paradiso et al., 2011; Okamoto et al., 2003; Pallud et al 2008; Hellier and 
Dudek, 2005). This has given rise to the “double hit” hypothesis for the  
pathogenesis of MTLE. According to this hypothesis, there is an initial event, 
either occurring early on in life (e.g. prolonged febrile seizures or SE 
occurring very early post-natally), or during adolescence/early adulthood 
(subtle ischemic/traumatic insult? Subtle cortical malformations giving rise to 
focal unnoticed epileptic discharges?) (Loscher and Brandt, 2010; Baram et al., 
2011), which might be responsible for the onset of plastic phenomena which, 
at least in some patients, give rise to the onset of SRS.  
AHS has been considered for more than 50 years as a potential pathological 
substrate for the onset of SRS in MTLE. In fact, from a pathological and 
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functional point of view, there are several aspects of AHS which might justify 
such an assumption: a) there is a selective loss of GABAergic interneurons at 
the level of the hilus of the DG; b) there is a marked sprouting of the mossy 
fibers (the MFS above described), which causes auto-excitation of the 
glutamatergic granule cells by their axon terminals. c) several studies in vitro 
have shown a hyperexcitability of the hippocampus bearing AHS signs 
(Blumcke et al., 2000). 
Other authors, however, think that this anatomical alteration is not sufficient 
by itself to cause SRS and to justify seizure susceptibility in MTLE. They 
claim, for instance, that: a) kindling of different limbic regions, such as the 
amygdala, the piriform cortex or the hippocampus itself, are not usually 
associated with AHS, even though they are often associated to the 
development of SRS (Brandt et al., 2004; Muller et al., 2009). b) in rats in 
which MFS has been prevented by protein synthesis blockage, SRS after SE 
have been shown by some authors (Longo and Mello, 1997). 
AHS has been observed to occur with the classical models of limbic SE by 
KA or pilocarpine (Curia et al., 2008; Bouillere et al., 2000); in both models it 
has been shown the occurrence of SRS (Brandt et al., 2003). However, both of 
these models bear the huge disadvantage of inducing a widespread damage 
throughout the whole brain, which is likely to be largely independent of SE, 
but rather a concomitant phenomenon (see for instance Sloviter, 2009). Thus, 
both the occurrence of AHS, and the presence of SRS might be due to 
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one/some different lesions occurring in the rodents experiencing this SE.  
Conversely, by profiting of the model of APC microinfusions, we can test the 
sole effect of the spreading of seizures via the anatomical physiological 
pathways of the limbic system. The picomolar amount of chemoconvulsants 
microinfused in this model do not spread for more than 1 mm apart from the 
site of infusion and thus do not affect the diffusion of seizures to other sites of 
the limbic system and brain. Furthermore, by this experimental approach it is 
possible to discriminate the effect of sporadic seizures versus prolonged 
seizures (SE) in determining the onset of late SRS, while KA or pilocarpine 
give rise only to an all-or-nothing phenomenon, i.e. their lightest seizure effect 
is SE! 
As already mentioned, there are at present two different models of SE evoked 
from the APC, which have been developed in the last few years (Fornai et al., 
2005; Giorgi et al., 2003). In one case SE is evoked by co-administering 2 
substances (cyclothiazide and bicuculline) into APC in intact rats, and in the 
other one the simple administration of low dosages of bicuc ulline into the 
APC, in rats which have been submitted to LC lesion, induces prolonged SE.  
As outlined in the introduction, LC seems to play a critical role in the 
expression of IEGs, which are genes involved in the generation of plastic 
mechanisms, such as learning and memory phenomena (for a review, see 
Giorgi et al., 2006). We have recently shown that the lesion of LC 
significantly affects the pattern of expression of c-Fos protein after SE evoked 
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from the APC. 
At present, nobody has ever investigated whether SE evoked from the APC is 
associated with SRS, the presence and role of AHS in this model, and, 
eventually, the role of LC in these phenomena. The latter aspect is particularly 
important due to the lack of enough information from human studies, and the 
fact that, however, LC neurons decrease throughout adult life in humans.  
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2.  Specific aims 
In this study we wanted to test: 
A) Whether there are EEG and behavioral differences between the SE 
induced by APC in the presence of intact LC and that induced by the same site 
in rats bearing a lesion of LC. 
B) Whether sporadic seizures evoked from the APC are sufficient to 
induce SRS. 
C) Whether the model of SE induced by APC, either in the presence or in 
the absence of LC, is associated to the development of SRS, i.e. whether one 
of the two models can be considered as a good model of epilepsy, rather than 
acute seizures only. 
D) Whether the model of SE induced by APC is associated with the 
classical hallmarks of human MTLE, such as AHS and MFS. 
E) Whether the lack of NE affects the presence of AHS and MFS, and in 
parallel the onset of SRS, or rather these phenomena are, at least in part, 
independent from one another. 
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3.  Methods 
 
3.1 Animals  
We used male Sprague Dawley rats aged between 90 and 120 days at the time 
of seizure induction (weight 200-250 g). They were kept under controlled 
environmental conditions and handled in accordance with the Guidelines for 
Animal Care and Use of the National Institutes of Health 
 
3.2 Experimental design (Figure 5) 
Rats were microinfused with chemoconvulsants or saline into the APC at t=0; 
they were monitored behaviorally and by EEG starting at t=0 and for up to 
document the last seizure. Animals were submitted either to sporadic limbic 
seizures (by bicuculline 118 pmol infused into APC) or to SE. SE was induced 
by a) microinfusing cyclothiazide and bicuculline, 3 min. apart, into the APC 
in rats bearing an intact LC (“Cy+Bic” group); b) by microinfusing 
bicuculline into the APC of animals in which it had been induced a selective 
LC lesion 2 weeks before (“DSP-4+Bic” group). In the following weeks they 
were monitored both behaviorally and, in some cases, by EEG. They were 
sacrificed either 45 days (T1), or 90 days (T2) after the induction of seizures, 
and their brains were collected and processed for morphological analysis. (See 
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figure 5) 
 
3.3 Stereotactic surgery (Figure 6) 
Rats were deeply anesthetized with chloral hydrate (400 mg / kg), and were 
placed in a the Stereotactic Koppf apparatus for small animals; their skull was 
secured to the stereotactic frame through interaural and dental bars; the dental 
bar was set at + 5 mm, in order to complain with the stereotactic coordinates 
of the atlas of Pellegrino et al. (1979).  
For each animal a 0.71 mm external diameter stainless steel guide cannula 
(Plastics One, Roanoke, VA, USA) was inserted through a hole drilled in the 
skull, and secured with dental acrylic cement and screws. Stereotaxic 
coordinates for the tip of the internal cannula (see below) were as follows: 
AP=+4 mm from the bregma, ML=+3.3 mm from the midline, DV=−6.5 mm 
below the dura (according to the atlas of Pellegrino et al., 1979), 
corresponding to the APC, as described by Piredda and Gale (1985). After 
surgery, rats were allowed to recover for 24 h in their home cage with ad 
libitum access to food and water. 
For drug microinfusions, the internal cannula (0.36 mm external diameter, 17 
mm long; Plastics One) was inserted, extending 1 mm beyond the tip of the 
guide cannula. The internal cannula was connected via polyethylene tubing to 
a Hamilton syringe (10 μL) driven by a microinfusion pump. After the end of 
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each infusion, the internal cannula was left in place for 1 min in order to 
ensure complete delivery of the drug. (See figure 6) 
 
3.4 Acute seizures monitoring 
During and after microinfusions, each rat was placed in a 25×30 cm clear 
plastic cage; we started to assess convulsive behavior immediately after 
starting microinfusion, and continued for 2 h after the end of the last recorded 
ictal event.  
For each rat we measured the following parameters: a) seizure latency; b) 
seizure duration (when seizures were sporadic and SE did not occur); c) 
seizure onset and duration of SE, and d) mean seizure severity.  
In particular, seizure severity was evaluated according to the following score 
modified from Racine (1972): 0.5=jaw clonus; 1=myoclonus of contralateral 
forelimb; 2=forelimb clonus lasting 5–15 seconds; 3=bilateral forelimb clonus 
lasting more than 15 s; 4= rearing, with concomitant bilateral forelimb clonus; 
5=rearing with loss of balance and concomitant forelimb +/− hindlimb clonus; 
finally, we recorded the onset of SE, defined as seizure activity lasting, 
without any interruption, for at least 30 min.  
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3.5 Electroencephalography 
In the same surgical procedure as above we placed into the skull epidural 
electrodes for EEG recording. In particular, by a microdrill, for each rat we 
produced two symmetrical holes under the frontal bones and two ones under 
the parietal bones and another hole was performed in the occipital bone. Then, 
we placed into each hole a microelectrode (see below), thus obtaining, 
respectively, left frontal (F1), right frontal (F2), left parietal (P1) and right 
parietal (P2) electrodes, plus the reference electrode above the cerebellum 
(Ref). 
The guide cannula introduced, as well as electrodes and their wires were 
blocked in situ by bi-component dental acrylic cement.  
The electrodes were prepared in our laboratory by use of stainless steel 
micro-screws (0.5 mm diameter) whose cap was soldered with shielded wire 4 
mm in length, ending with female pins. During each EEG recording session, 
each female pin was connected to the male pin of a cable connected to the 
head of the EEG preamplifier (see below). These electrodes were screwed 
through microholes (see above) into the skull of the animal for about 2 mm, to 
record epidural EEG activity. 
Once verified through the acquisition software the correct functioning of the 
electrodes (i.e.impedance <0.5 Ohm), EEG signal was pre-amplified through a 
BE-Lite® preamplifier (EBNeuro, Italy), notch-filtered, acquired at 128 bit, 
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and stored in a windows-equipped PC, through the acquisition software 
GALNT® (EBNeuro), for off-line analysis of seizure activity. This is 
typically defined as a sequence of “spikes” or “sharp waves”, or amplitude of 
“tips waves”> 150 microvolts and in sequences lasting> 5 seconds. Episodes 
of electric SE were defined by continuous seizure activity lasting> 30’, as 
opposed to intermittent sporadic electrographic seizures, lasting usually < 1 
min, and separated by normal background EEG. 
Starting at one week after seizure induction, rats were monitored for 
occurrence of SRS, both behaviorally and EEGraphically, with 2h of 
monitoring/day, five days a week, by an observer blinded to the experimental 
groups.  
Results were collected in two sequential sets of experiments, and pooled for 
the final data analysis. 
 
3.6 Lesion of the Locus Coeruleus 
Some rats were submitted to a LC lesion three days prior to seizure induction 
(“DSP-4+ saline” group and “DSP-4+Bic” group) by administration of DSP-4 
(60 mg / kg, ip) . DSP-4 has been previously shown to selectively lesion NE 
fibers originating from the LC, at appropriate dosage, which in rats is 
approximately 60 mg/kg (Johnson et al., 1981; Giorgi 2003, 2006). 
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3.7 Seizure induction  
SE was induced two days after implantation of the cannula in APC: seizures 
were induced by micro-infusion of 118 pmol bicuculline in APC during two 
minutes, by using a Hamilton syringe connected to a 10-microliter micropump 
for micro-infusion. The micro-infusion volume was 200 nl, to avoid producing 
harmful effects in local APC, mechanical damage due to the infusion per se.  
In DSP-4 + bicuculline group the SE was induced by micro-infusion of 
bicuculline in animals with injured LC (systemic administration of DSP-4 
three days before). In the group “Cy+Bic”, SE in animals with intact LC by 
microinfusinng 200 nl cyclothiazide 1.2 nmol in 2 minutes, followed the 
micro-infusion of bicuculline after a minute (200 nl, 118 pmol). 
 
3.8 Histology 
Rats were sacrificed either 45 or 90 days after seizure induction, and their 
brains were subjected to histological investigation. In particular, after deep 
anesthesia animals were perfused trans-cardiacally with saline (100ml/rat, 0.9% 
v/v) solution, followed by neutral formalin (200ml/rat); the brains were then 
removed and immersed into the same fixative for further 12 hours at 4°C. 
Then they were cryoprotected through immersion in sucrose solution, and 
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stired at 4°C till precipitation. Then, these brains were frozen at -80 º C in 
isopentane. Frozen brains were stored at -80°C till cut. 
For morphological analysis brains were cut into 20 µm thick coronal sections 
at crystat. Cryosections were mounted on slides and subjected to different 
staining: 
a) cresyl violet (for evaluation of neuronal counts and hippocampal pyramidal 
cells),  
b) immunohistochemistry for glial fibrillary acidic protein (GFAP) (as an 
indicator of reactive gliosis),  
c) immunohistochemistry for parvalbumin (PVA), a marker of peptides 
co-transmitters of hippocampal inhibitory interneurons. 
a) The cresyl violet protocol was: 1 min distilled H2O；Cresyl (time as a color) 
1 min； H2O few sec； Ethanol 80 ° a few seconds；Ethanol 96 ° a few 
seconds； Absolute ethanol few sec； Xylene；Xylene cleaned；Mounting slide 
with DPX 
We used the classical cresyl violet solution (2.5gr of cresyl violet in 300 ml of 
distilled H2O+ 30 ml 1M sodium acetate+ 170 ml 1M glacial acetic acid). 
The immunohistochemical protocol included: washing in PBS (Phosphate 
buffered saline), blocking in hydrogen peroxide, then washing in PBS, 
blocking serum (3% NGS in PBS for 2 hours in a humid chamber), treat with 
antibody IIrio for 12 hours (incubation chamber) at 4 ° C (PVA 1:3000, 
1:1000 GFAP; in 1% NGS in PBS). The slides were washed in PBS in the 
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next day, then exposed IIry antibody (1:200 in PBS 1% NGS) for 2 hours (in a 
humid chamber), and then washed three times in PBS. Then, slides were 
incubated with ABC kit (Sigma, Milano), and immunostaining was revealed 
by black reaction after adding DAB (3,3'-Diaminobenzidine) to the 
solution. Eventually, slides were subjected to serial passages of 5 minutes in 
increasing concentrations of ethanol (50%, 70%, 90% overall), then dipped in 
xylene and mounted with cover slips. 
A subgroup of rats was perfused via trans-cardiac with saline, followed by 
saline containing 0.37% of NaS2 and neutral formalin. These brains were used 
for the histochemical method of “TIMM staining”, which selectively stain the 
mossy fibers originating from granule cells of the DG, through reaction with 
the Zn, which is contained, in the hippocampus, selectively in that subclass of 
neuronal fibers. Briefly, fixed brains were frozen and cut as described above 
for immunoistochemistry. The slices were mounted on polylysine slides, and 
then kept for 4 hours at 40°C and overnight at room temperature, in order to 
promote a stronger attachment to the slides. Afterward they were immersed in 
the TIMM solution, in light-protected glass slide keepers for 70 min’. The 
TIMM solution we use is composed by a partition of a 60:10:30:0.5 vol/vol 
mixture of gum Arabic solution (50gr/100ml), 2.25 M citrate buffer solution 
(23.5g C6H5Na3O7·2H2O/100ml, 23.3gC6H8O7/100ml), 0.5 M 
hydroquinone solution, and 0.04% silver lactate solution (all from Sigma) 
according to Armitage et al. (1998). Sections were slightly counterstained 
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with cresyl violet (as counterstaining), and then dehydrated gradually in 
ethanol, clarified with xylene and coverslipped.  
The occurrence of mossy fiber sprouting into the inner molecular layer of the 
DG was evaluated by an observer blind to treatments, by using a qualitative 
score from Cavazos et al. (1991).   
  
3.9 Semiquantitative damage evaluation 
The number of pyramidal neurons in hippocampal CA 1 and CA3 and hilar 
neurons of the DG was estimated by a semiquantitative count  of neurons per 
field at fixed 30x magnification of 5 sections (4 sections apart) per animal, 
with the first analyzed section placed at the same level of the dorsal 
hippocampus (approximately AP= -3.8 mm, according to the atlas by Paxinos 
and Watson, 1997). For each area the data were expressed as % + %SEM 
compared to control (saline or bicuculline microinfusion within ACP). Areas 
were analyzed only for the hemisphere ipsilateral to the infusion site. 
For TIMM staining, we used a score of Cavazos et al. (1991): the score for 
each animal was calculated ipsilaterally to the infusion site, analyzing 4-6 
hippocampal sections per animal: 0 = no granules between the tips and crest of 
the DG; 1 = sparse granules in the supragranular region in a patchy 
distribution between the tips and crest of the dentage gyrus; 2 = more 
numerous granules in the supragranular region in a continuous distribution 
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between the tips and crest of the DG; and 3 = prominent granules in the 
supragranular region in a continuous pattern between tips and crest, with 
occasional patches of confluent granules between tips and crests of the DG; 4 
= prominent granules in the supragranular region that form a confluent dense 
laminar band between tips and crest; 5 = confluent dense laminar band of 
granules in the supragranular region that extends into the IML 
 
3.10 Statistical analysis 
Data on the duration and severity of seizures, both acute and chronic, as well 
as the number of neurons in various areas, and TIMM scores, were expressed 
as mean + SEM, and comparisons between different experimental groups 
were performed with analysis of variance associated with Scheffe post-hoc 
analysis. The data on percentage of animals with the seizure were assessed by 
Chi-Square analysis. Statistical differences were considered significant at p 
<0.05. 
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Chapter 3 Results 
1. Acute seizures (Figure 7) 
Both in the group with intact LC treated with cyclothiazide + bicuculline 
(“Cy+Bic”, n = 16), and in those treated with bicuculline after LC lesion 
("DSP-4+Bic”, n = 16), we observed SE in all animals. In particular, the 
seizure began in both groups approximately three min after bicuculline 
infusion (latency of 3.4+0.5 and 3.2+0.7, respectively). In the two groups, the 
total duration of the seizure was respectively 143+16, and 154+18 minutes, 
and in both groups most of that time was spent on SE, i.e. in continuous 
seizure, albeit carachterized by alternating periods of seizures with different 
scores. Even the maximum seizure score was similar in the 2 groups of 
animals, i.e. a score of 4 in almost all rats. Control rats microinfused with 
bicuculline (n=4) developed only sporadic seizures lasting not longer than a 
total of 40 min (from first to last episode), as expected from previous studies 
(data not shown). 
 
2. Chronic monitoring (Figure 8) 
We didn’t observe the onset of SRS in any of the rat microinfused with either 
saline or bicuculline bearing an intact LC, nor in any rats treated with DSP-4 
+saline. Conversely, in animals treated with cyclothiazide + bicuculline, or 
with DSP-4 + bicuculline, we observed the onset of SRS. However, while this 
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was the case only for 12.5% of rats treated with cyclothiazide + bicuculline, 
both at 45 and 90 days, in animals treated with DSP-4 + bicuculline we found 
an incidence of 25% and 37.5% of SRS at the two time points, respectively. In 
both groups, however, the severity of SRS was similar: seizures were always 
focal in nature, since the maximal seizure severity never exceeded the score of 
2. In no case we could observe spontaneous episodes of SE, chronically.  
 
3. Electroencephalography (Figure 9) 
At the EEG, we could not show any significant difference between the two 
groups: Cy+Bic and DSP-4+Bic. In particular, at approximately 3 min after 
APC microinfusion, there were sporadic spikes and sharp waves, which were 
at first in short trains lasting few seconds, intermingled by normal EEG 
background (Figure 9B). These periods of epileptiform activity became more 
prolonged and confluent with each other, up to the onset of long trains of 
spikes/spike-wave discharges lasting > 30’ each (SE) (Figure 9C). Such an 
effect was similar in the two groups of rats.   
 
4. Morphological data (Figure 10, 11) 
The analysis with cresyl violet showed a significant reduction in the number 
of neurons in the DG hilus in both groups submitted to SE, both at 45 and 90 
days (Figure 10). Furthermore, within each SE group such a reduction was 
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greater at 90 than that at 45 days. However, when comparing the cell loss 
degree in the two SE groups, we found that, both at 45 days and 90 days after 
SE, the hilar cell loss was higher in the DSP-4+bicuculline group than in the 
cyclothiazide+bicuculline group. 
 
The loss in CA3 neurons (Figure 11) showed a similar trend, although in this 
case the lesion was significantly higher in the group treated with 
DSP-4+bicuculline against bicuculline + cyclothiazide only at 45 days after 
SE.  
 
Hippocampal reactive gliosis (Figure 12A) (as measured by a 
semiquantitative scale, evaluating the expression of GFAP), was significantly 
present in both SE groups, and to a similar extent, at 90 days after treatment.  
The loss of PVA –positive interneurons (Figure 12B) was significant in both 
groups with SE, even though more marked in the DSP-4 + bicuculline group.  
 
Finally, the mossy fibers sprouting of the DG (Figure 13) (as detected by 
TIMM score) was significantly increased in the group treated with 
cyclothiazide and bicuculline compared to control, and in a time-dependent 
fashion (i.e. greater at 90 days than at 45 days after SE). For both time 
intervals, TIMM score was much greater in the group bicuculline+ 
cyclothiazide than that in the group of DSP-4 + bicuculline .  
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Chapter 4 Conclusions 
In this study we demonstrated that, even though it was almost identical in 
terms of seizure duration, severity, and electroencephalographic features, the 
SE evoked locally from the APC induces different effects, depending on the 
presence or absence of intact LC noradrenergic fibers.  
In particular, we showed that the SRS occur to a higher degree after lesion of 
the LC. This is the first time we were able to document the onset of SRS in the 
model of limbic SE by Cyclothiazide+Biocuculline, at two chronic time points 
(45 and 90 days post-SE), while we confirmed that sporadic seizures evoked 
from the APC in intact rats do not give rise to SRS (see also Giorgi, 2006). 
This confirms the validity of this model of SE as a model of epileptogenicity, 
just than barely a model of acute seizures. As opposed to other existing limbic 
SE models, induced by systemic chemoconvulsants (e.g. the kainate and 
pilocarpine model, see Introduction section), in the focal SE model we used 
we can rule out any “epileptogenic” effect of the systemic chemoconvulsant in 
sites distant from the site of seizure induction: the SRS we observed in this 
study are solely the effect of a process of secondary epileptogenesis induced 
by a propagation of the seizures through the natural pathways recruited by the 
seizures themselves. 
Even in rats bearing a lesion of LC, and not submitted to focal seizures , we 
could not observe, as expected, SRS. Conversely, in rats bearing a lesion LC 
before SE induction we observed SRS, with a significantly higher intensity 
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than after SE in intact rats. 
There are many evidences for a role of MFS, in the pathogenesis of SRS after 
limbic SE (see for instance Gorter et al., 2001), since it has been repeatedly 
suggested that MFS might be associated with hyperexcitability of the 
hippocampus. In our study, we showed that in the group DSP-4+Bic the 
TIMM score (i.e. the entity of MFS) was much lower than in the group 
Cy+Bic, as opposed to the incidence of SRS. However, when we evaluated the 
occurrence of other features of AHS in the two SE groups, we found that in 
the group bearing a lesioned LC the CA3 and hilar cell loss was significantly 
higher than in rats with intact LC, especially concerning hilar neurons. We 
confirmed by PVA immunoistochemistry, that such a loss was affecting 
specifically the PVA-positive GABAergic interneurons, which have been 
claimed to play a particularly relevant role in determining hippocampal 
hyperxcitability (see for instance van Vliet et al., 2004). 
There are some possible explanations for the discordance we observed 
between MFS and SRS incidence after SE in LC-lesioned rats. In one scenario, 
the level of MFS we found in LC pre-lesioned rats, even though lower than in 
the Cy+Bic group, is still significantly higher than in bicuculline or control 
rats. Such an effect might be sufficient to trigger the onset of SRS, and a more 
marked MFS (as observed in the group Cy+Bic) might not add further efficacy. 
Thus, in this scenario, the higher incidence of SRS might depend mainly on 
the higher interneuron loss in the hippocampus hilus.   
Chapter 4 Conclusion 
59 
The hypothesis of the lack of a significant, exclusive role of MFS in SRS was 
proposed by Longo and Mello (1997) several years ago, and might find some 
confirmation in this study. 
As to why the absence of NA endogenous causes a greater depletion in 
neuronal equal to duration and type of SE, compared to rats with intact LC, it 
is important to notice that a potential effect of LC absence on other types of 
neuronal damage (iatrogenic) has been shown repeatedly in the last years. For 
example, it is known that a previous lesion to the fibers of the LC by DSP-4 
(the neurotoxin used in these experiments) significantly enhances the 
dopaminergic toxicity induced by amphetamine derivatives in mice and by 
neurotoxin MPTP in rats, mice and in monkeys (Fornai et al., 1996; Mavridis 
et al., 1991; for a review see Gesi et al., 2000). The mechanisms responsible 
for this enhancement are unknown and go beyond this study but may involve 
inhibition of production of growth factors. However, it is known that the LC 
plays an important role in many neuronal and synaptic plasticity mechanisms. 
This is confirmed by the relevant role of LC in determining the expression of 
immediate early genes, i.e. genes which are involved in plastic mechanisms. 
Recently, Giorgi et al. showed that focal SE evoked by the APC in DSP-4 
pretreated rats is associated to a significantly lower expression of c -Fos in 
several brain areas, including the hippocampus, as compared to the group 
Cy-Bic.  
Finally, it is worth being mentioned that during physiological ageing, it has 
Chapter 4 Conclusion 
60 
been shown that there is a progressive significant decrease in NE content in 
the brain, mainly due to an ongoing degeneration of LC neurons: TLE has 
been shown to affect significantly more frequently aged people as compared 
to young patients, and the phenomena we showed in this study, in an 
experimental model, might at least in part justify this epidemiological data.  
In Conclusion: this study provides new insights of interest on the pathogenesis 
of temporal lobe epilepsy. To date there are no reliable methods in vivo for 
monitoring the activity of LC in humans, but this study, along with previous 
ones performed in other experimental models of epilepsy, strongly suggests a 
role of this brain nucleus in MTLE pathogenesis. 
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Table 1-3 
Table 1   Epilepsy syndromes  
Groups of Syndromes Specific Syndromes 
Idiopathic Focal Epilepsies of Infancy 
and Childhood 
Benign Infantile Seizures (Non-Familial) 
Benign Childhood Epilepsy with Centrotemporal Spikes 
Early Onset Benign Childhood Occipital Epilepsy (Panayiotopoulos type) 
Late Onset Childhood Occipital Epilepsy (Gastaut type) 
Familial (Autosomal Dominant) Focal 
Epilepsies 
Benign Familial Neonatal Seizures  
Benign Familial Infantile Seizures  
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy 
Familial Temporal Lobe Epilepsy 
Familial Focal Epilepsy with Variable Foci* 
Symptomatic (or Probably Symptomatic) 
Focal Epilepsies 
Limbic Epilepsies 
 Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis 
 Mesial Temporal Lobe Epilepsy Defined by Specifi c Etiologies 
 Other Types Defined by Location and Etiology 
Neocortical Epilepsies 
 Rasmussen Syndrome 
 Hemiconvulsion - Hemiplegia Syndrome 
 Other Types Defined by Location and Etiology 
 Migrating Partial Seizures of Early Infancy *  
Idiopathic Generalized Epilepsies  Benign Myoclonic Epilepsy in Infancy  
Epilepsy with Myoclonic Astatic Seizures 
Childhood Absence Epilepsy 
Epilepsy with Myoclonic Absences 
Idiopathic Generalized Epilepsies with Variable Phenotypes  
 Juvenile Absence Epilepsy  
 Juvenile Myoclonic Epilepsy 
 Epilepsy with Generalized Tonic-Clonic Seizures Only 
Generalized Epilepsies with Febrile Seizures Plus* 
Refl ex Epilepsies Idiopathic Photosensitive Occipital Lobe Epilepsy 
Other Visual Sensitive Epilepsies 
Primary Reading Epilepsy 
Startle Epilepsy 
  Epileptic Encephalopathies (in which the 
epileptiform abnormalities may 
contribute to progressive dysfunction) 
Early Myoclonic Encephalopathy 
Ohtahara Syndrome 
West Syndrome 
Dravet Syndrome (Previously Known as Severe Myoclonic Epilepsy in Infancy)  
Myoclonic Status in Non-Progressive Encephalopathies 
Lennox-Gastaut Syndrome 
Landau-Kleffner Syndrome 
Epilepsy with Continuous Spike-Waves during Slow Wave Sleep 
Progressive Myoclonus Epilepsies Epilepsy with generalized tonic-clonic seizures  
Seizures Not Necessarily Requiring a 
Diagnosis of Epilepsy 
Benign Neonatal Seizures. Febrile Seizures. Reflex Seizures. Alcohol Withdrawal Seizures. 
Drug or Other Chemically-Induced Seizures. Immediate and early Post Traumatic Seizures. 
Single Seizures or Isolated Clusters of Seizures. Rarely Repeated Seizures (Oligo-Epilepsy) 
*In development 
According the commision of the ILAE (1989, 2006)  
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Table 2   Experimental models of neurological diseases 
  
Requires of an “ideal model” Objectives of an “ideal model” 
To reproduce the neuropathological alterations 
of the disease 
Understanding the pathogenesis  
To reproduce the pathophysiology of the 
disease 
Understanding the anatomical pathways 
underlying the symptoms of the disease 
To induce a behavioral framework 
reproducing, even with obvious phylogenetical 
limits, and the symptoms of patients suffering 
from the disease 
Discovering new 'targets' against which to 
direct specific therapy 
To respond to the same treatment of human 
disease 
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Table 3   Experimental animal models of seizure  
       
 
 
 
 
 
Experimental animal models of focal 
seizure 
 
 
 
neocortical 
1)electrical stimulation (acute) 
2)Topical application of chemoconvulsants (eg. 
penicillin, bicuculline, picrotoxin)  
3)Topical application of metals (eg. alumina gel, 
cobalt, iron chloride)  
4) neocortical Kindling   
 
limbic 
1)electrical stimulation (acute) 
2)Kindling of the amygdala or hippocampus 
3)systemic/i.c.v. kainate  
4) Pilocarpine low-dose systemic or i.c.v.  
5)Micro-infusion in Area Tempestas 
6)perforant pathway stimulation 
 
 
 
 
 
 
Some animal models of generalized 
seizures 
 
 
Grand mal 
1)Maximal electroshock seizure (MES) 
2)Administration of high doses of Penthylentetrazol 
(PTZ) 
3)Administration of high doses of flurothyl 
4)Audiogenic massive seizures 
 
Petit Mal 
1)Systemic Penicillin (in cats) 
2)PTZ at low doses 
3)Opioids i.c.v. 
4)GHB systemic 
 
 
Genetic 
model 
1) Primates Papio Papio 
2) Mice with audiogenic seizure 
3) Genetically epilepsy prone rat (GEPR) 
4) Seizure-prone gerbil 
5) Tottering mice 
6) Spontaneous spike and wave rat model 
Other ....... 
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Figure 1-13 
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rat
monkey
human
Dubach & Gale
Figure 2 Conservation of the APC through phylogenesis
 
 
Nissl staining control
Nissl staining MTLE
TIMM staining MTLE
Fisher, Sperber and Moshé, 1998
Figure 3 Ammon's horn sclerosis in human temporal lobe epilepsy
PLASTIC MODIFICATION:
“mossy fiber sprouting”.
Is the aberrant fiber proliferation of
glutamatergic granule cells of DG
which form autoexcitatory circuits
projecting to the dendrites of the
granule cells themselves in the inner
molecular layer of the DG
NEURON LOSS IN THE HILUS OF DENTATE
GYRUS, IN HIPPOCAMPAL CA1 AND CA3
REGIONS:
In the DG hilus there is a massive loss of
GABAergic interneurons, among which the
PVA positive neurons seem to play the main
role
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Figure 4 The nucleus Locus Coeruleus
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Chemoconvulsants
APC
Figure 6             Stereotactic surgery in rat
Site of the infusion
APC
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Figure 7. In the two model of SE evoked from the APC, we showed a similar 
incidence of SE among microinfused animals (A), as well as a similar severity 
of the SE (B). 
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DSP-4
90 days
Figure 8 Occurrence of the spontaneous recurrent seizure after SE
(secondary epileptogenesis)
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Figure 8.The behavior of animals was evaluated ( and in some case by EEG) 
for 1 hour /day for 5 days a week until sacrifice after 45 or 90 days of SE. A) 
The SRSs were observed only in the two groups with SE, but with higher 
frequency in the group DSP-4 + bicuculline than that in group cyclothiazide + 
bicuculline. B) In both SE groups the SRSs are not intense, and with a score 
suggesting a focal origin  
 
 
 
Tables and Figures  
70 
 
 
 
Figure 9. The figure shows representative EEGs obtained in animals from the 
two groups of SE: cyclothiazide+bicuculline (left column), and 
DSP-4+bicuculline (right column). The EEG bearing epileptiform activity 
(B-D), strongly differs from that obtained in basal conditions ( A). 
B. In both models we showed at around 3’ after bicuculline microinfusion, the 
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onset of sporadic seizures (the two EEGs show the recruiting activity, at the 
onset of a score 3 seizure); 
C. The EEG at around 2 h after SE onset is similar in the two groups, showing 
a continuous Spike/spike-wave discharge on all of the EEG channels (stage 4 
seizures, i.e. generalized seizures); 
D. Chronically, both groups show SRS, which, when recorded at EEG, show 
similar features of short duration and representation mainly on the anterior 
regions (low score seizures).Abbreviations: F1: left frontal electrode; F2: right 
frontal electrode; P1: left parietal electrode; P2: right parietal electrode; Ref: 
reference electrode. 
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Figure 10 Neuron loss in the hilus of the dentate gyrus
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Figure 10. In the hemisphere ipsilateral to the infusion site in APC, there is a 
depletion of neurons in the hilus of DG at 45 or 90 days from the induction of 
SE. In the group group DSP-4+bicuculline such a loss is higher than in the 
group cyclothiazide+bicuculline, at both time intervals.  
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Figure 11 Loss of hippocampal CA3 neurons 
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Figure11. In the hemisphere ipsilateral to the infusion site in APC, there was a 
depletion of pyramidal neurons in the CA3 area of hippocampus at 45 days or 
90 days from the SE induction. In the group group DSP-4+bicuculline such a 
loss is higher than in the group cyclothiazide+bicuculline, at the 45 days 
interval. 
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Figure 12. In the hemisphere ipsilateral to the infusion site in APC, at 90 days 
after SE induction, there was a significant reactive gliosis, as testified by the 
semiquantitative evaluation of the expression of GFAP(A); there was not a 
significant difference between the two groups. Further, we found in both 
groups a significant depletion of PVA-positive interneurons in the hilus of the 
DG (B), which was greater in DSP-4+bicuculline group than that in 
cyclothiazide+bicuculline group 
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Figure 13. At 45 days or 90 days from the SE induction, we found a 
significant sprounting of glutamatergic mossy fibers originating from 
granule cells of the DG in the ipsilateral hemisphere to the site of infusion in 
APC, as testified by the score of TIMM staining. A) The TIMM’s score in rats 
treated by saline, cyclothiazide +bicuculline or DSP-4 +bicuculline. TIMM’s 
score increased in both groups with SE but more in the rats with intact LC 
than that in rats bearing a lesioned LC. B) low magnification image, showing 
the level at which the analysis was performed, C) representative images in the 
three groups at 90 days.  
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Abbreviations 
APC:                                      Anterior Piriform Cortex 
AHS:                                      Ammon’s Horn Sclerosis 
AEDs :                                         Anti-epileptic drugs 
AMPA:       2-amino-3-(5-methyl-3-oxo-1,2- oxazol-4-yl) propanoic acid 
AMPAR:                                                    AMPA receptor 
BNDF:                              Brain-derived neurotrophic factor 
BBB:                                           Blood brain barrier  
CA:                                               Ammon’s Horn 
CNS:                                       Central nervous system  
CREB:                         Cyclic-AMP response element binding  
DAB:                                       3,3'-Diaminobenzidine 
DSP-4:                 N-(2-Chloroethyl)-N-ethyl-2-bromobenzylamine 
DG:                                               Dentate Gyrus  
DHPG:                              (S)-3,5-dihydroxyphenylglycine  
DBH:                                   Dopamine-beta-hydroxylase 
ERK:                          Extracellular Signal-Regulated Kinases 
EEG:                                      Electroencephalography  
GABA:                                 Gamma-Aminobutyric Acid 
GABAr:                          Gamma-Aminobutyric Acid receptor 
GAD:                                  Glutamic acid decarboxylase 
GBRG2:                      GABA(A) receptor gamma2 subunit gene  
Abbreviation  
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GFAP:                                   Glial fibrillary acid protein 
GABA(A)/cBZR:             GABA(A)/central Benzodiazepine receptor 
GEPRs:                               Genetically epilepsy prone rats  
IEGs:                                        Immediate early genes  
i.c.v:                                        Intracerebroventricular 
IPSCs:                     Spontaneous inhibitory postsynaptic currents  
KARs:                                                       kainate receptor 
KA:                                                  Kainic acid  
LGICs:                                   Ligand-gated ion channels 
LC:                                              Locus coeruleus 
MRI:                                   Magnetic resonance imaging  
MTLE:                                Mesial temporal lobe epilepsy  
MFS:                                      Mossy Fiber Sprouting 
mGLuRs:                            metabotropic glutamate receptors 
NMDA:                                      N-Methyl-D-aspartate 
NMDA:                                      N-Methyl-D-aspartate 
NMDAr:                              N-Methyl-D-aspartate receptor 
NBQX:    2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione 
NGS:                                                     Normal goat serum 
NE:                                               Norepinephrine 
nAChR :                              nicotinic acetylcholine receptor 
PDS:                                  Paroxysmal depolarizing shift  
Abbreviation  
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PTZ:                                             Pentylentetrazol 
PVA:                                                Parvalbumin  
PBS:                                      Phosphate buffered saline  
SE:                                              Status epilepticus  
SRS:                                  Spontaneous recurrent seizures  
SEM:                                    Standard error of the mean 
VDCC:                           voltage-dependent calcium channels 
WT:                                                   Wild ty pe 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
